CLEC12A (蛋白 | 抗体 | cDNA 克隆 | ELISA 试剂盒)

All CLEC12A reagents are produced in house and quality controlled, including 1 CLEC12A Antibody, 32 CLEC12A Gene, 1 CLEC12A Lysate, 1 CLEC12A Protein, 2 CLEC12A qPCR. All CLEC12A reagents are ready to use.

CLEC12A Protein (1)

    CLEC12A Antibody (1)

      CLEC12A cDNA Clone (32)

      BC126289

      In lentiviral vector

      NM_177686.3

      克隆载体 cDNA 产品

      In lentiviral vector

      NM_001134716.1

      CLEC12A Lysate (1)

        CLEC12A 分子背景

        CLEC12A is a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily. Members of this family share a common protein fold and have diverse functions, such as cell adhesion, cell-cell signaling, glycoprotein turnover, and roles in inflammation and immune response. CLEC12A is a negative regulator of granulocyte and monocyte function. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. C-type lectins are the most diverse and prevalent lectin family in immunity. Using a novel CLEC12A -specific monoclonal antibody, experiments had shown that human CLEC12A was expressed primarily on myeloid cells, including granulocytes, monocytes, macrophages, and dendritic cells. Although CLEC12A was highly N-glycosylated in primary cells, the level of glycosylation was found to vary between cell types. CLEC12A surface expression was down-regulated during inflammatory/activation conditions in vitro, as well as during an in vivo model of acute inflammation. This suggests that CLEC12A may be involved in the control of myeloid cell activation during inflammation.

        CLEC12A 参考文献

        • Lahoud MH, et al. (2009) The C-type lectin Clec12A present on mouse and human dendritic cells can serve as a target for antigen delivery and enhancement of antibody responses. J Immunol. 182(12): 7587-94.
        • Pyz E, et al. (2008) Characterisation of murine MICL (CLEC12A) and evidence for an endogenous ligand. Eur J Immunol. 38(4): 1157-63.
        • Marshall AS, et al. (2006) Human MICL (CLEC12A) is differentially glycosylated and is down-regulated following cellular activation. Eur J Immunol. 36(8): 2159-69.

        Note: Flag® is a registered trademark of Sigma Aldrich Biotechnology LP. It is used here for informational purposes only.